Episode Details

Back to Episodes
Biana Torres on her transition into Cell & Gene Therapy leadership.

Biana Torres on her transition into Cell & Gene Therapy leadership.

Season 2 Episode 19 Published 1ย year, 9ย months ago
Description

In todayโ€™s episode, I was joined by Biana Torres, Senior Director of Quality Assurance at Encoded Therapeutics.

I really wanted to speak to Biana because she has built a strong leadership career in quality, moving through both big pharma and small biotech. Sheโ€™s now leading in the dynamic world of cell and gene therapy, where quality and adaptability are critical.

Biana started out aiming to be a doctor, pivoted into biotech by accident, and has since built a career leading quality teams through acquisitions, evolving regulations, and high-impact projects that put patients first.

We talk about the following:

๐ŸŽ™๏ธ Her unexpected entry into quality through a temp job at Baxter

๐ŸŽ™๏ธ The transition from big pharma to small biotech and what she learned from both

๐ŸŽ™๏ธ Why cell & gene therapy is different from traditional small molecule and biologics

๐ŸŽ™๏ธ How quality leadership has evolved from being "the police" to a business partner

๐ŸŽ™๏ธ The impact of working at Kite during a pivotal time for the industry

๐ŸŽ™๏ธ How she overcame the "no CGT experience, no interview" hiring barrier

๐ŸŽ™๏ธ The mindset shift needed to work in advanced therapies

๐ŸŽ™๏ธ The importance of coaching & mentorship in leadership development

๐ŸŽ™๏ธ Why future quality leaders need to think outside the box

Biana is a passionate leader who thrives in fast-moving biotech environments. Sheโ€™s driven by curiosity, continuous learning, and a commitment to mentoring the next generation of quality leaders.

Thank you, Biana, for sharing your incredible journey.

Hope everyone enjoys the show!

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us